Establishing a bone marrow stromal cell transplant program at the national institutes of health clinical center

Tissue Engineering - Part B: Reviews

Volumn 20, Issue 3, 2014, Pages 200-205

  Stroncek, David F ^a   Sabatino, Marianna ^a   Ren, Jiaqiang ^a   England, Lee ^a   Kuznetsov, Sergei A ^b   Klein, Harvey G ^a   Robey, Pamela G ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENGINEERING; INDUSTRIAL ENGINEERING;

BONE MARROW STROMAL CELLS; CARDIO-VASCULAR DISEASE; FETAL BOVINE SERUM; GRAFT-VERSUS-HOST DISEASE; HEALTHY SUBJECTS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INFLAMMATORY BOWEL DISEASE; NATIONAL INSTITUTES OF HEALTH;

BONE;

LIQUID NITROGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ALGORITHM; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOMATION; BIOREACTOR; BONE MARROW BIOPSY; BONE MARROW CELL; BONE MARROW STROMAL CELL; CARDIOVASCULAR DISEASE; CELL LYSATE; CORONARY ARTERY DISEASE; CRYOPRESERVATION; DONOR; HEALTH CARE FACILITY; HEALTH PROGRAM; HEART FAILURE; HUMAN; INFLAMMATORY BOWEL DISEASE; MICROBIAL CONTAMINATION; MULTIPOTENT STEM CELL; NATIONAL HEALTH SERVICE; PRIORITY JOURNAL; QUALITY CONTROL PROCEDURES; STROMA CELL; THROMBOCYTE; TISSUE CULTURE; ANIMAL; BATCH CELL CULTURE; CELL CULTURE; CYTOLOGY; GOVERNMENT; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; NATIONAL HEALTH ORGANIZATION; ORGANIZATION AND MANAGEMENT; PHYSIOLOGY; STEM CELL RESEARCH; TISSUE ENGINEERING; UNITED STATES;

ANIMALS; BATCH CELL CULTURE TECHNIQUES; BIOLOGICAL SPECIMEN BANKS; CELLS, CULTURED; GOVERNMENT PROGRAMS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NATIONAL INSTITUTES OF HEALTH (U.S.); STEM CELL RESEARCH; TISSUE ENGINEERING; UNITED STATES;

EID: 84901308976     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2013.0529     Document Type: Article

References (37)

1. Kuznetsov, S.A., Huang, K.E., Marshall, G.W., Robey, P.G., and Mankani, M.H. Long-term stable canine mandibular augmentation using autologous bone marrow stromal cells and hydroxyapatite/tricalcium phosphate. Biomaterials 29, 4211, 2008.
2. Mankani, M.H., Kuznetsov, S.A., Shannon, B., Nalla, R.K., Ritchie, R.O., Qin, Y., et al. Canine cranial reconstruction using autologous bone marrow stromal cells. Am J Pathol 168, 542, 2006.
3. Mankani, M.H., Kuznetsov, S.A., Wolfe, R.M., Marshall, G.W., and Robey, P.G. In vivo bone formation by human bone marrow stromal cells: reconstruction of the mouse calvarium and mandible. Stem Cells 24, 2140, 2006.
4. Krebsbach, P.H., Mankani, M.H., Satomura, K., Kuznetsov, S.A., and Robey, P.G. Repair of craniotomy defects using bone marrow stromal cells. Transplantation 66, 1272, 1998.
5. Bruder, S.P., Kurth, A.A., Shea, M., Hayes, W.C., Jaiswal, N., and Kadiyala, S. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 16, 155, 1998.
6. Quarto, R., Mastrogiacomo, M., Cancedda, R., Kutepov, S.M., Mukhachev, V., Lavroukov, A., et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344, 385, 2001.
7. Marcacci, M., Kon, E., Moukhachev, V., Lavroukov, A., Kutepov, S., Quarto, R., et al. Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng 13, 947, 2007.
8. Kitoh, H., Kitakoji, T., Tsuchiya, H., Katoh, M., and Ishiguro, N. Transplantation of culture expanded bone marrow cells and platelet rich plasma in distraction osteogenesis of the long bones. Bone 40, 522, 2007.
9. Singer, N.G., and Caplan, A.I. Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol 6, 457, 2011.
10. Ren, G., Chen, X., Dong, F., Li, W., Ren, X., Zhang, Y., et al. Concise review: mesenchymal stem cells and translational medicine: emerging issues. Stem Cells Transl Med 1, 51, 2012.
11. Zhou, Y., Wang, S., Yu, Z., Hoyt, R.F., Jr., Sachdev, V., Vincent, P., et al. Direct injection of autologous mesenchymal stromal cells improves myocardial function. Biochem Biophys Res Commun 390, 902, 2009.
12. Hare, J.M., Traverse, J.H., Henry, T.D., Dib, N., Strumpf, R.K., Schulman, S.P., et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 54, 2277, 2009.
13. Mankani, M.H., Kuznetsov, S.A., Marshall, G.W., and Robey, P.G. Creation of new bone by the percutaneous injection of human bone marrow stromal cell and HA/TCP suspensions. Tissue Eng Part A 14, 1949, 2008.
14. Ringden, O., Uzunel, M., Rasmusson, I., Remberger, M., Sundberg, B., Lonnies, H., et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81, 1390, 2006.
15. Le, B.K., Rasmusson, I., Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363, 1439, 2004.
16. Le, B.K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371, 1579, 2008.
17. Sabatino, M., Ren, J., David-Ocampo, V., England, L., McGann, M., Tran, M., et al. Establishment of a bank of stored clinical bone marrow stromal cell products. J Transl Med 10, 23, 2012.
18. von, B.L., Sundberg, B., Lonnies, L., Sander, B., Karbach, H., Hagglund, H., et al. Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy. Biol Blood Marrow Transplant 18, 557, 2012.
19. Kebriaei, P., Isola, L., Bahceci, E., Holland, K., Rowley, S., McGuirk, J., et al. Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. Biol Blood Marrow Transplant 15, 804, 2009.
20. Allison, M. Genzyme backs Osiris, despite Prochymal flop. Nat Biotechnol 27, 966, 2009.
21. Ren, J., Stroncek, D.F., Zhao, Y., Jin, P., Castiello, L., Civini, S., et al. Intra-subject variability in human bone marrow stromal cell (BMSC) replicative senescence: molecular changes associated with BMSC senescence. Stem Cell Res 11, 1060, 2013.
22. Wagner, W., Ho, A.D., and Zenke, M. Different facets of aging in human mesenchymal stem cells. Tissue Eng Part B Rev 16, 445, 2010.
23. Ksiazek, K. A comprehensive review on mesenchymal stem cell growth and senescence. Rejuvenation Res 12, 105, 2009.
24. Banfi, A., Muraglia, A., Dozin, B., Mastrogiacomo, M., Cancedda, R., and Quarto, R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 28, 707, 2000.
25. Digirolamo, C.M., Stokes, D., Colter, D., Phinney, D.G., Class, R., and Prockop, D.J. Propagation and senescence of human marrow stromal cells in culture: a simple colonyforming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107, 275, 1999.
26. Sethe, S., Scutt, A., and Stolzing, A. Aging of mesenchymal stem cells. Ageing Res Rev 5, 91, 2006.
27. Kuznetsov, S.A., Krebsbach, P.H., Satomura, K., Kerr, J., Riminucci, M., Benayahu, D., et al. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 12, 1335, 1997.
28. Selvaggi, T.A., Walker, R.E., and Fleisher, T.A. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 89, 776, 1997.
29. Schallmoser, K., and Strunk, D. Generation of a pool of human platelet lysate and efficient use in cell culture. Methods Mol Biol 946, 349, 2013.
30. Bernardi, M., Albiero, E., Alghisi, A., Chieregato, K., Lievore, C., Madeo, D., et al. Production of human platelet lysate by use of ultrasound for ex vivo expansion of human bone marrow-derived mesenchymal stromal cells. Cytotherapy 15, 920, 2013.
31. Huisman, E.L., van Eerd, M.C., Ouwens, J.N., and de Peuter, M.A. Cost-effectiveness and budget impact study of solvent/detergent (SD) treated plasma (octaplasLG(R)) versus fresh-frozen plasma (FFP) in any patient receiving transfusion in Canada. Transfus Apher Sci 2013 [Epub ahead of print]; DOI: 10.1016/j.transci.2013.04.045.
32. Stroncek, D.F., Jin, P., Wang, E., and Jett, B. Potency analysis of cellular therapies: the emerging role of molecular assays. J Transl Med 5, 24, 2007.
33. Solchaga, L.A., and Zale, E.A. Prostaglandin E2: a putative potency indicator of the immunosuppressive activity of human mesenchymal stem cells. Am J Stem Cells 1, 138, 2012.
34. Liu, G.Y., Xu, Y., Li, Y., Wang, L.H., Liu, Y.J., and Zhu, D. Secreted galectin-3 as a possible biomarker for the immunomodulatory potential of human umbilical cord mesenchymal stromal cells. Cytotherapy 15, 1208, 2013.
35. De, B.C., Dell'accio, F., Karystinou, A., Guillot, P.V., Fisk, N.M., Jones, E.A., et al. A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum 58, 240, 2008.
36. Shin, J.W., Jin, P., Fan, Y., Slezak, S., vid-Ocampo, V., Khuu, H.M., et al. Evaluation of gene expression profiles of immature dendritic cells prepared from peripheral blood mononuclear cells. Transfusion 48, 647, 2008.
37. Wang, H., Jin, P., Sabatino, M., Ren, J., Civini, S., Bogin, V., et al. Comparison of endometrial regenerative cells and bone marrow stromal cells. J Transl Med 10, 207, 2012.